Glaxo Wellcome Advair Compliance To Be Studied Following Approval
Executive Summary
Glaxo Wellcome plans to look for improved patient compliance with Advair Diskus compared to other asthma treatments in post-marketing studies.
You may also be interested in...
Glaxo's Advair Combo Gets Broad Asthma Indication From FDA
Glaxo Wellcome's Advair Diskus will carry a broad indication for asthma patients requiring combination beta agonist/corticosteroid therapy.
Glaxo's Advair Combo Gets Broad Asthma Indication From FDA
Glaxo Wellcome's Advair Diskus will carry a broad indication for asthma patients requiring combination beta agonist/corticosteroid therapy.
Flovent Diskus Would Be Useful Option With Advair Diskus - FDA Cmte.
Glaxo Wellcome's Flovent Diskus would be a useful option for titration in conjunction with the Advair Diskus, FDA's Pulmonary-Allergy Drugs Advisory Committee suggested at its Nov. 23 meeting.